

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sequestering of actin monomers (GO:0042989) | 6.43743115 |
| 2 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.20452682 |
| 3 | barbed-end actin filament capping (GO:0051016) | 4.64469024 |
| 4 | regulation of protein heterodimerization activity (GO:0043497) | 4.57972621 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.34892744 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.33396391 |
| 7 | actin nucleation (GO:0045010) | 3.88017032 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 3.69643524 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 3.69643524 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.69643524 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.69643524 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.69643524 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 3.69643524 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.64739672 |
| 15 | negative regulation of cell killing (GO:0031342) | 3.64739672 |
| 16 | respiratory burst (GO:0045730) | 3.57110955 |
| 17 | endosome to pigment granule transport (GO:0043485) | 3.49876532 |
| 18 | endosome to melanosome transport (GO:0035646) | 3.49876532 |
| 19 | negative regulation of phagocytosis (GO:0050765) | 3.42990426 |
| 20 | cellular response to nicotine (GO:0071316) | 3.03996715 |
| 21 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.02497263 |
| 22 | modulation by virus of host process (GO:0019054) | 2.96888018 |
| 23 | modulation by symbiont of host cellular process (GO:0044068) | 2.86257126 |
| 24 | viral protein processing (GO:0019082) | 2.84412256 |
| 25 | negative regulation of glial cell proliferation (GO:0060253) | 2.84160496 |
| 26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.84158529 |
| 27 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.82825501 |
| 28 | mannose metabolic process (GO:0006013) | 2.82468492 |
| 29 | regulation of mast cell degranulation (GO:0043304) | 2.82381609 |
| 30 | response to muramyl dipeptide (GO:0032495) | 2.81016209 |
| 31 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.79987698 |
| 32 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.78719007 |
| 33 | positive regulation of macrophage differentiation (GO:0045651) | 2.78069414 |
| 34 | positive regulation of myotube differentiation (GO:0010831) | 2.75607827 |
| 35 | neutrophil activation (GO:0042119) | 2.75076523 |
| 36 | regulation of skeletal muscle contraction (GO:0014819) | 2.72592214 |
| 37 | regulation of leukocyte degranulation (GO:0043300) | 2.72251303 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.71030741 |
| 39 | response to host immune response (GO:0052572) | 2.69338505 |
| 40 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.69338505 |
| 41 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.67596618 |
| 42 | positive regulation of antigen processing and presentation (GO:0002579) | 2.67223124 |
| 43 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.66438742 |
| 44 | regulation of histone phosphorylation (GO:0033127) | 2.66128370 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.65900760 |
| 46 | regulation of necrotic cell death (GO:0010939) | 2.64679349 |
| 47 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.62562269 |
| 48 | virion assembly (GO:0019068) | 2.62257348 |
| 49 | negative regulation of microtubule polymerization (GO:0031115) | 2.60857418 |
| 50 | membrane budding (GO:0006900) | 2.60713601 |
| 51 | granulocyte activation (GO:0036230) | 2.60385730 |
| 52 | platelet dense granule organization (GO:0060155) | 2.59912088 |
| 53 | detection of bacterium (GO:0016045) | 2.59863058 |
| 54 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.59783386 |
| 55 | regulation of regulated secretory pathway (GO:1903305) | 2.59155764 |
| 56 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.59116945 |
| 57 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.59083458 |
| 58 | cellular response to zinc ion (GO:0071294) | 2.58532977 |
| 59 | detection of other organism (GO:0098543) | 2.58491857 |
| 60 | adenosine receptor signaling pathway (GO:0001973) | 2.56637080 |
| 61 | respiratory system process (GO:0003016) | 2.56549849 |
| 62 | neurofilament cytoskeleton organization (GO:0060052) | 2.55603288 |
| 63 | regulation of ARF GTPase activity (GO:0032312) | 2.55208834 |
| 64 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.55075010 |
| 65 | axon extension involved in axon guidance (GO:0048846) | 2.55075010 |
| 66 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.54745411 |
| 67 | negative regulation of necrotic cell death (GO:0060547) | 2.53898109 |
| 68 | regulation of monocyte chemotaxis (GO:0090025) | 2.53694608 |
| 69 | response to host (GO:0075136) | 2.52066010 |
| 70 | response to host defenses (GO:0052200) | 2.52066010 |
| 71 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.52066010 |
| 72 | regulation of early endosome to late endosome transport (GO:2000641) | 2.50672954 |
| 73 | macrophage activation involved in immune response (GO:0002281) | 2.48371886 |
| 74 | NIK/NF-kappaB signaling (GO:0038061) | 2.46704637 |
| 75 | immunoglobulin mediated immune response (GO:0016064) | 2.46059244 |
| 76 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.45428600 |
| 77 | response to peptidoglycan (GO:0032494) | 2.45186693 |
| 78 | positive regulation of T cell apoptotic process (GO:0070234) | 2.44560214 |
| 79 | response to parathyroid hormone (GO:0071107) | 2.43695884 |
| 80 | regulation of antigen processing and presentation (GO:0002577) | 2.43482638 |
| 81 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.43319387 |
| 82 | mitochondrion transport along microtubule (GO:0047497) | 2.43319387 |
| 83 | cell migration in hindbrain (GO:0021535) | 2.43179194 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.43061980 |
| 85 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.42718025 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.42437200 |
| 87 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.42233529 |
| 88 | anterograde synaptic vesicle transport (GO:0048490) | 2.41411318 |
| 89 | protein localization to endosome (GO:0036010) | 2.40702587 |
| 90 | lipopolysaccharide metabolic process (GO:0008653) | 2.39999834 |
| 91 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.39438721 |
| 92 | regulation of ARF protein signal transduction (GO:0032012) | 2.39099505 |
| 93 | creatine metabolic process (GO:0006600) | 2.38917000 |
| 94 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.38727529 |
| 95 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.38188609 |
| 96 | leukocyte aggregation (GO:0070486) | 2.37647942 |
| 97 | peripheral nervous system neuron development (GO:0048935) | 2.37140948 |
| 98 | stress fiber assembly (GO:0043149) | 2.36692506 |
| 99 | membrane invagination (GO:0010324) | 2.36387662 |
| 100 | actin-myosin filament sliding (GO:0033275) | 2.35343446 |
| 101 | muscle filament sliding (GO:0030049) | 2.35343446 |
| 102 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.34708552 |
| 103 | purine-containing compound salvage (GO:0043101) | 2.34148383 |
| 104 | histamine secretion (GO:0001821) | 2.32423074 |
| 105 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.32017526 |
| 106 | positive thymic T cell selection (GO:0045059) | 2.31617337 |
| 107 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.30240683 |
| 108 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.30114601 |
| 109 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.30114601 |
| 110 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.30052984 |
| 111 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.28141469 |
| 112 | positive regulation of extracellular matrix organization (GO:1903055) | 2.28006630 |
| 113 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.27546913 |
| 114 | negative regulation of interleukin-12 production (GO:0032695) | 2.27477978 |
| 115 | myeloid cell homeostasis (GO:0002262) | 2.27356993 |
| 116 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.27130413 |
| 117 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.26940281 |
| 118 | enteric nervous system development (GO:0048484) | 2.26799857 |
| 119 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.26394277 |
| 120 | phagocytosis, engulfment (GO:0006911) | 2.25057762 |
| 121 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.24948446 |
| 122 | viral transcription (GO:0019083) | 2.24524012 |
| 123 | regulation of defense response to virus by virus (GO:0050690) | 2.22340508 |
| 124 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.22265819 |
| 125 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.22205260 |
| 126 | de novo posttranslational protein folding (GO:0051084) | 2.22138851 |
| 127 | establishment of mitochondrion localization (GO:0051654) | 2.21551838 |
| 128 | myeloid cell activation involved in immune response (GO:0002275) | 2.21364469 |
| 129 | amino sugar catabolic process (GO:0046348) | 2.20684995 |
| 130 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.20300171 |
| 131 | positive regulation of lamellipodium assembly (GO:0010592) | 2.20103181 |
| 132 | positive regulation of mast cell activation (GO:0033005) | 2.19998955 |
| 133 | nucleobase catabolic process (GO:0046113) | 2.19979347 |
| 134 | modulation by virus of host morphology or physiology (GO:0019048) | 2.19619351 |
| 135 | actin filament polymerization (GO:0030041) | 2.19149128 |
| 136 | detection of molecule of bacterial origin (GO:0032490) | 2.17746904 |
| 137 | germinal center formation (GO:0002467) | 2.16620894 |
| 138 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.16192540 |
| 139 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.15578199 |
| 140 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.15542118 |
| 141 | platelet aggregation (GO:0070527) | 2.14583316 |
| 142 | positive regulation of interferon-alpha production (GO:0032727) | 2.14565707 |
| 143 | negative regulation of cell size (GO:0045792) | 2.14507762 |
| 144 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.14428430 |
| 145 | negative regulation of actin filament polymerization (GO:0030837) | 2.13793738 |
| 146 | tooth mineralization (GO:0034505) | 2.13768715 |
| 147 | response to nerve growth factor (GO:1990089) | 2.13409072 |
| 148 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.13409072 |
| 149 | positive regulation of histone deacetylation (GO:0031065) | 2.13172355 |
| 150 | facial nerve structural organization (GO:0021612) | 2.13050579 |
| 151 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.12948606 |
| 152 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.12885042 |
| 153 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.12491559 |
| 154 | cellular extravasation (GO:0045123) | 2.12488071 |
| 155 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.11923389 |
| 156 | negative regulation of granulocyte differentiation (GO:0030853) | 2.10689170 |
| 157 | positive regulation of fibroblast migration (GO:0010763) | 2.09587180 |
| 158 | regulation of female receptivity (GO:0045924) | 2.09220637 |
| 159 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.08988759 |
| 160 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.08777513 |
| 161 | pigment granule organization (GO:0048753) | 2.08090823 |
| 162 | leukocyte cell-cell adhesion (GO:0007159) | 2.07870532 |
| 163 | melanosome organization (GO:0032438) | 2.07849931 |
| 164 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.07656658 |
| 165 | positive regulation of mast cell degranulation (GO:0043306) | 2.07656658 |
| 166 | cell-cell junction maintenance (GO:0045217) | 2.07427083 |
| 167 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.07374150 |
| 168 | negative regulation of necroptotic process (GO:0060546) | 2.07263066 |
| 169 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.06870048 |
| 170 | positive regulation of regulated secretory pathway (GO:1903307) | 2.06811764 |
| 171 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.05754820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19515636 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.14674737 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.14227417 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.90665245 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.87550678 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.76018072 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69598818 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69559791 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.62104318 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.59497272 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.46266986 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.45824856 |
| 13 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.28151419 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25162808 |
| 15 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.17708296 |
| 16 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.16338537 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.16235945 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.12529365 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.11978508 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11400527 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.07336175 |
| 22 | KDM2B_26808549_Chip-Seq_K562_Human | 2.06446019 |
| 23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.05238788 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.02549690 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.01248899 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.00976008 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98778293 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.94603356 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94471802 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.92755339 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.92674983 |
| 32 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.90095299 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87337424 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.86271325 |
| 35 | P68_20966046_ChIP-Seq_HELA_Human | 1.84916116 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84828254 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84635550 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81691530 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79452579 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78887119 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.78574102 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76305465 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.71306652 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70721457 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.70161434 |
| 46 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.69823620 |
| 47 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.68572038 |
| 48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.68174646 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.62358219 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.62236056 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58023962 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.57259547 |
| 53 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.57196712 |
| 54 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57091595 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55022917 |
| 56 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.53324873 |
| 57 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.52072992 |
| 58 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51610889 |
| 59 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.49781347 |
| 60 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.49713062 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49532297 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.49376164 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.48528056 |
| 64 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.48176363 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.47771099 |
| 66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.47306165 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44278552 |
| 68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.43659275 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43071431 |
| 70 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.42676250 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42112458 |
| 72 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41640107 |
| 73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39274210 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38260639 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35273573 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34909639 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.33006203 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32266592 |
| 79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30969072 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30539648 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30312814 |
| 82 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.28974269 |
| 83 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.28658041 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28635067 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28503747 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28202487 |
| 87 | SA1_27219007_Chip-Seq_Bcells_Human | 1.27532764 |
| 88 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.26718677 |
| 89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25889280 |
| 90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25848737 |
| 91 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24985180 |
| 92 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.24845063 |
| 93 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.24211900 |
| 94 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23978549 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23657349 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23381080 |
| 97 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.23120072 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22858344 |
| 99 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22167199 |
| 100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.21334768 |
| 101 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.21189895 |
| 102 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.20667513 |
| 103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20038787 |
| 104 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.19435623 |
| 105 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19306751 |
| 106 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17469441 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.17456334 |
| 108 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17042579 |
| 109 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.16864888 |
| 110 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.15881763 |
| 111 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.14950332 |
| 112 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.14690320 |
| 113 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14662926 |
| 114 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.14399654 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14120537 |
| 116 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13842195 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13352444 |
| 118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13326519 |
| 119 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.13275883 |
| 120 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13192400 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12853444 |
| 122 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.11566981 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11014305 |
| 124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09212301 |
| 125 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09034268 |
| 126 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08347432 |
| 127 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.07716525 |
| 128 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07395773 |
| 129 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05849601 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05375182 |
| 131 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04433742 |
| 132 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.04238733 |
| 133 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04046422 |
| 134 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03851089 |
| 135 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03117168 |
| 136 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02715369 |
| 137 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.02576478 |
| 138 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02460320 |
| 139 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.02089087 |
| 140 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.02046389 |
| 141 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01546154 |
| 142 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01399692 |
| 143 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00815988 |
| 144 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00721823 |
| 145 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98937279 |
| 146 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98558911 |
| 147 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98343117 |
| 148 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.98316899 |
| 149 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.98264307 |
| 150 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98205433 |
| 151 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.97998143 |
| 152 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.95670938 |
| 153 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.95608310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.65775507 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.41412705 |
| 3 | MP0003436_decreased_susceptibility_to | 3.04811553 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.73359712 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.40520826 |
| 6 | MP0004858_abnormal_nervous_system | 2.31109547 |
| 7 | MP0009840_abnormal_foam_cell | 2.22211940 |
| 8 | MP0000685_abnormal_immune_system | 2.21824778 |
| 9 | MP0000751_myopathy | 2.20935160 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.19589770 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.18862457 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.16690116 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.15735163 |
| 14 | MP0004130_abnormal_muscle_cell | 2.08286960 |
| 15 | MP0009785_altered_susceptibility_to | 2.00295264 |
| 16 | MP0002419_abnormal_innate_immunity | 2.00003886 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 1.96756360 |
| 18 | MP0006054_spinal_hemorrhage | 1.96379608 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 1.94860918 |
| 20 | MP0006276_abnormal_autonomic_nervous | 1.94505765 |
| 21 | MP0004859_abnormal_synaptic_plasticity | 1.94499514 |
| 22 | MP0005025_abnormal_response_to | 1.93909120 |
| 23 | MP0001958_emphysema | 1.90860341 |
| 24 | MP0003123_paternal_imprinting | 1.83340572 |
| 25 | MP0002405_respiratory_system_inflammati | 1.82390514 |
| 26 | MP0003279_aneurysm | 1.80049943 |
| 27 | MP0005174_abnormal_tail_pigmentation | 1.78431874 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.73348321 |
| 29 | MP0000749_muscle_degeneration | 1.72837232 |
| 30 | MP0009278_abnormal_bone_marrow | 1.72631464 |
| 31 | MP0006082_CNS_inflammation | 1.72201795 |
| 32 | MP0002751_abnormal_autonomic_nervous | 1.71166762 |
| 33 | MP0000569_abnormal_digit_pigmentation | 1.70507380 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.69912427 |
| 35 | MP0010030_abnormal_orbit_morphology | 1.69843131 |
| 36 | MP0000343_altered_response_to | 1.68977010 |
| 37 | MP0000750_abnormal_muscle_regeneration | 1.67643083 |
| 38 | MP0000858_altered_metastatic_potential | 1.66804152 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.66291406 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.65977401 |
| 41 | MP0001819_abnormal_immune_cell | 1.65866864 |
| 42 | MP0001348_abnormal_lacrimal_gland | 1.65478673 |
| 43 | MP0008260_abnormal_autophagy | 1.64328600 |
| 44 | MP0005503_abnormal_tendon_morphology | 1.62876020 |
| 45 | MP0001790_abnormal_immune_system | 1.62487819 |
| 46 | MP0005387_immune_system_phenotype | 1.62487819 |
| 47 | MP0004510_myositis | 1.59513223 |
| 48 | MP0000759_abnormal_skeletal_muscle | 1.54854228 |
| 49 | MP0005671_abnormal_response_to | 1.54364875 |
| 50 | MP0002723_abnormal_immune_serum | 1.53386890 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.52555437 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.51046930 |
| 53 | MP0003075_altered_response_to | 1.50207069 |
| 54 | MP0002822_catalepsy | 1.49830566 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.47678969 |
| 56 | MP0002132_abnormal_respiratory_system | 1.46957684 |
| 57 | MP0002398_abnormal_bone_marrow | 1.41282608 |
| 58 | MP0001800_abnormal_humoral_immune | 1.39384152 |
| 59 | MP0003879_abnormal_hair_cell | 1.39267752 |
| 60 | MP0003329_amyloid_beta_deposits | 1.38898311 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.38066950 |
| 62 | MP0002933_joint_inflammation | 1.37543454 |
| 63 | MP0003724_increased_susceptibility_to | 1.35546354 |
| 64 | MP0000747_muscle_weakness | 1.35230937 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.33490822 |
| 66 | MP0000490_abnormal_crypts_of | 1.33391723 |
| 67 | MP0001873_stomach_inflammation | 1.30453573 |
| 68 | MP0005257_abnormal_intraocular_pressure | 1.29170279 |
| 69 | MP0003448_altered_tumor_morphology | 1.28641485 |
| 70 | MP0005390_skeleton_phenotype | 1.28024944 |
| 71 | MP0000681_abnormal_thyroid_gland | 1.27138841 |
| 72 | MP0000716_abnormal_immune_system | 1.25984999 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.24073168 |
| 74 | MP0002429_abnormal_blood_cell | 1.19004857 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.18311927 |
| 76 | MP0001853_heart_inflammation | 1.18304767 |
| 77 | MP0005666_abnormal_adipose_tissue | 1.18008754 |
| 78 | MP0003303_peritoneal_inflammation | 1.17878462 |
| 79 | MP0001663_abnormal_digestive_system | 1.17779194 |
| 80 | MP0008874_decreased_physiological_sensi | 1.15429897 |
| 81 | MP0000604_amyloidosis | 1.15071172 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.14597050 |
| 83 | MP0002332_abnormal_exercise_endurance | 1.14480735 |
| 84 | MP0001845_abnormal_inflammatory_respons | 1.14372019 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 1.13249985 |
| 86 | MP0001545_abnormal_hematopoietic_system | 1.13249985 |
| 87 | MP0008004_abnormal_stomach_pH | 1.12527927 |
| 88 | MP0005423_abnormal_somatic_nervous | 1.12307908 |
| 89 | MP0000372_irregular_coat_pigmentation | 1.11169813 |
| 90 | MP0002733_abnormal_thermal_nociception | 1.10120310 |
| 91 | MP0002106_abnormal_muscle_physiology | 1.09024691 |
| 92 | MP0004087_abnormal_muscle_fiber | 1.08319455 |
| 93 | MP0004947_skin_inflammation | 1.08051223 |
| 94 | MP0003183_abnormal_peptide_metabolism | 1.06919590 |
| 95 | MP0005275_abnormal_skin_tensile | 1.06914714 |
| 96 | MP0003646_muscle_fatigue | 1.06503360 |
| 97 | MP0000767_abnormal_smooth_muscle | 1.06290183 |
| 98 | MP0005166_decreased_susceptibility_to | 1.03771547 |
| 99 | MP0002282_abnormal_trachea_morphology | 1.03769413 |
| 100 | MP0003091_abnormal_cell_migration | 1.02673669 |
| 101 | MP0003763_abnormal_thymus_physiology | 1.02609736 |
| 102 | MP0002736_abnormal_nociception_after | 1.00767619 |
| 103 | MP0001542_abnormal_bone_strength | 1.00002939 |
| 104 | MP0005375_adipose_tissue_phenotype | 0.99488918 |
| 105 | MP0002722_abnormal_immune_system | 0.98702392 |
| 106 | MP0000689_abnormal_spleen_morphology | 0.98497105 |
| 107 | MP0004883_abnormal_blood_vessel | 0.98149540 |
| 108 | MP0004036_abnormal_muscle_relaxation | 0.96892805 |
| 109 | MP0001968_abnormal_touch/_nociception | 0.96540526 |
| 110 | MP0005409_darkened_coat_color | 0.95342661 |
| 111 | MP0004233_abnormal_muscle_weight | 0.95139423 |
| 112 | MP0000678_abnormal_parathyroid_gland | 0.94350704 |
| 113 | MP0003787_abnormal_imprinting | 0.93354283 |
| 114 | MP0000733_abnormal_muscle_development | 0.92892954 |
| 115 | MP0001849_ear_inflammation | 0.91909924 |
| 116 | MP0008789_abnormal_olfactory_epithelium | 0.91816162 |
| 117 | MP0005381_digestive/alimentary_phenotyp | 0.91300216 |
| 118 | MP0003866_abnormal_defecation | 0.88738930 |
| 119 | MP0010155_abnormal_intestine_physiology | 0.88543211 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.87241168 |
| 121 | MP0005394_taste/olfaction_phenotype | 0.87008971 |
| 122 | MP0005499_abnormal_olfactory_system | 0.87008971 |
| 123 | MP0008995_early_reproductive_senescence | 0.86013505 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.83816095 |
| 125 | MP0009764_decreased_sensitivity_to | 0.83684564 |
| 126 | MP0001727_abnormal_embryo_implantation | 0.82821603 |
| 127 | MP0000538_abnormal_urinary_bladder | 0.82366270 |
| 128 | MP0003453_abnormal_keratinocyte_physiol | 0.81465703 |
| 129 | MP0003186_abnormal_redox_activity | 0.81419697 |
| 130 | MP0005369_muscle_phenotype | 0.81000434 |
| 131 | MP0003828_pulmonary_edema | 0.80184637 |
| 132 | MP0000049_abnormal_middle_ear | 0.79765478 |
| 133 | MP0000703_abnormal_thymus_morphology | 0.79414059 |
| 134 | MP0002938_white_spotting | 0.79289857 |
| 135 | MP0002102_abnormal_ear_morphology | 0.78988454 |
| 136 | MP0003942_abnormal_urinary_system | 0.78302938 |
| 137 | MP0002653_abnormal_ependyma_morphology | 0.77931765 |
| 138 | MP0005023_abnormal_wound_healing | 0.77759670 |
| 139 | MP0010386_abnormal_urinary_bladder | 0.76899986 |
| 140 | MP0003795_abnormal_bone_structure | 0.76516068 |
| 141 | MP0002396_abnormal_hematopoietic_system | 0.75506123 |
| 142 | MP0002089_abnormal_postnatal_growth/wei | 0.74935376 |
| 143 | MP0002113_abnormal_skeleton_development | 0.74797746 |
| 144 | MP0005083_abnormal_biliary_tract | 0.74750465 |
| 145 | MP0008469_abnormal_protein_level | 0.74637456 |
| 146 | MP0001970_abnormal_pain_threshold | 0.73715975 |
| 147 | MP0008569_lethality_at_weaning | 0.72677794 |
| 148 | MP0005508_abnormal_skeleton_morphology | 0.72381110 |
| 149 | MP0003705_abnormal_hypodermis_morpholog | 0.71705995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.45606144 |
| 2 | Exercise-induced myalgia (HP:0003738) | 4.24515856 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.22752943 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.21777359 |
| 5 | Myositis (HP:0100614) | 3.99629657 |
| 6 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.90003503 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 3.77557528 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.67293150 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.63947146 |
| 10 | Myopathic facies (HP:0002058) | 3.62661313 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 3.62027320 |
| 12 | Distal lower limb muscle weakness (HP:0009053) | 3.60572677 |
| 13 | Nemaline bodies (HP:0003798) | 3.56828079 |
| 14 | Orchitis (HP:0100796) | 3.50924370 |
| 15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.49192511 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.29057360 |
| 17 | Vertebral compression fractures (HP:0002953) | 3.24187929 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.20284563 |
| 19 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.16734304 |
| 20 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.01886983 |
| 21 | Asymmetric septal hypertrophy (HP:0001670) | 3.01708152 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 2.87682989 |
| 23 | Optic neuritis (HP:0100653) | 2.87682989 |
| 24 | Increased variability in muscle fiber diameter (HP:0003557) | 2.87066839 |
| 25 | Obstructive lung disease (HP:0006536) | 2.85297501 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 2.85297501 |
| 27 | Protrusio acetabuli (HP:0003179) | 2.82591791 |
| 28 | Ulnar deviation of the wrist (HP:0003049) | 2.81698426 |
| 29 | Purpura (HP:0000979) | 2.79781520 |
| 30 | Bulbar palsy (HP:0001283) | 2.76932432 |
| 31 | Difficulty running (HP:0009046) | 2.73456485 |
| 32 | Failure to thrive in infancy (HP:0001531) | 2.72890619 |
| 33 | Muscle stiffness (HP:0003552) | 2.68273675 |
| 34 | Increased connective tissue (HP:0009025) | 2.67729643 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.64821852 |
| 36 | Peritonitis (HP:0002586) | 2.64722946 |
| 37 | Hyporeflexia of lower limbs (HP:0002600) | 2.57021698 |
| 38 | Muscle fiber splitting (HP:0003555) | 2.55725511 |
| 39 | Gingivitis (HP:0000230) | 2.52635036 |
| 40 | Ulnar claw (HP:0001178) | 2.47804516 |
| 41 | Wrist flexion contracture (HP:0001239) | 2.47442042 |
| 42 | Petechiae (HP:0000967) | 2.46248953 |
| 43 | Glomerulonephritis (HP:0000099) | 2.44893494 |
| 44 | Easy fatigability (HP:0003388) | 2.43370698 |
| 45 | Achilles tendon contracture (HP:0001771) | 2.42078403 |
| 46 | Obstructive sleep apnea (HP:0002870) | 2.39604755 |
| 47 | Prolonged bleeding time (HP:0003010) | 2.39496973 |
| 48 | Increased IgM level (HP:0003496) | 2.37465137 |
| 49 | Distal lower limb amyotrophy (HP:0008944) | 2.36836885 |
| 50 | Abnormality of the anterior horn cell (HP:0006802) | 2.34149650 |
| 51 | Degeneration of anterior horn cells (HP:0002398) | 2.34149650 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.33180212 |
| 53 | Mediastinal lymphadenopathy (HP:0100721) | 2.32736868 |
| 54 | Round ear (HP:0100830) | 2.32503584 |
| 55 | Abnormality of dentin (HP:0010299) | 2.30874441 |
| 56 | Hyperthyroidism (HP:0000836) | 2.30015163 |
| 57 | Increased serum ferritin (HP:0003281) | 2.27810125 |
| 58 | Rhabdomyolysis (HP:0003201) | 2.25026228 |
| 59 | Nasal polyposis (HP:0100582) | 2.24197390 |
| 60 | Supranuclear gaze palsy (HP:0000605) | 2.22379566 |
| 61 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.21511863 |
| 62 | Cellulitis (HP:0100658) | 2.21446272 |
| 63 | Axonal loss (HP:0003447) | 2.21025367 |
| 64 | Albinism (HP:0001022) | 2.20481747 |
| 65 | J-shaped sella turcica (HP:0002680) | 2.19496820 |
| 66 | Thin bony cortex (HP:0002753) | 2.18721646 |
| 67 | Distal arthrogryposis (HP:0005684) | 2.18391810 |
| 68 | Neck muscle weakness (HP:0000467) | 2.17534979 |
| 69 | Recurrent skin infections (HP:0001581) | 2.17053873 |
| 70 | Increased IgE level (HP:0003212) | 2.16088416 |
| 71 | Hypochromic anemia (HP:0001931) | 2.16043101 |
| 72 | Slender build (HP:0001533) | 2.15560331 |
| 73 | Visual hallucinations (HP:0002367) | 2.15303012 |
| 74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14972599 |
| 75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14972599 |
| 76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14972599 |
| 77 | Abnormality of the nasal mucosa (HP:0000433) | 2.13190421 |
| 78 | Hypertensive crisis (HP:0100735) | 2.11989840 |
| 79 | Myotonia (HP:0002486) | 2.10764461 |
| 80 | Abnormality of the Achilles tendon (HP:0005109) | 2.09574163 |
| 81 | Mesangial abnormality (HP:0001966) | 2.09192353 |
| 82 | Waddling gait (HP:0002515) | 2.08637583 |
| 83 | EMG: myopathic abnormalities (HP:0003458) | 2.06193005 |
| 84 | Premature rupture of membranes (HP:0001788) | 2.03716878 |
| 85 | Beaking of vertebral bodies (HP:0004568) | 2.03209210 |
| 86 | Ankle clonus (HP:0011448) | 2.02163242 |
| 87 | Vasculitis (HP:0002633) | 1.99775450 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 1.98960819 |
| 89 | Cervical subluxation (HP:0003308) | 1.97591343 |
| 90 | Flexion contracture of toe (HP:0005830) | 1.97259981 |
| 91 | Joint contractures involving the joints of the feet (HP:0100492) | 1.97259981 |
| 92 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.95323188 |
| 93 | Hypothermia (HP:0002045) | 1.94578034 |
| 94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93695337 |
| 95 | Difficulty climbing stairs (HP:0003551) | 1.93493222 |
| 96 | Hypercortisolism (HP:0001578) | 1.93119846 |
| 97 | Stomatitis (HP:0010280) | 1.92352424 |
| 98 | Deformed sella turcica (HP:0002681) | 1.91740088 |
| 99 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.91519071 |
| 100 | Heterochromia iridis (HP:0001100) | 1.91231589 |
| 101 | Camptodactyly of toe (HP:0001836) | 1.90727815 |
| 102 | Diminished motivation (HP:0000745) | 1.88592323 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 1.87833936 |
| 104 | Myokymia (HP:0002411) | 1.87409181 |
| 105 | Spontaneous hematomas (HP:0007420) | 1.86951277 |
| 106 | Spinal rigidity (HP:0003306) | 1.86684778 |
| 107 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.86385806 |
| 108 | Increased density of long bones (HP:0006392) | 1.86381692 |
| 109 | Glomerulopathy (HP:0100820) | 1.85737119 |
| 110 | Gastrointestinal infarctions (HP:0005244) | 1.85606773 |
| 111 | Poor head control (HP:0002421) | 1.85213389 |
| 112 | Hepatosplenomegaly (HP:0001433) | 1.84238472 |
| 113 | Joint stiffness (HP:0001387) | 1.82727646 |
| 114 | Meningitis (HP:0001287) | 1.82318934 |
| 115 | Disinhibition (HP:0000734) | 1.81983610 |
| 116 | Recurrent fungal infections (HP:0002841) | 1.81702369 |
| 117 | Urticaria (HP:0001025) | 1.80979275 |
| 118 | EMG: neuropathic changes (HP:0003445) | 1.80744486 |
| 119 | Reticulocytopenia (HP:0001896) | 1.80129911 |
| 120 | Large eyes (HP:0001090) | 1.79917944 |
| 121 | Hypergammaglobulinemia (HP:0010702) | 1.79408821 |
| 122 | Lissencephaly (HP:0001339) | 1.79253791 |
| 123 | Hyperparathyroidism (HP:0000843) | 1.79208584 |
| 124 | Cerebral aneurysm (HP:0004944) | 1.78572084 |
| 125 | Growth hormone excess (HP:0000845) | 1.78556566 |
| 126 | Interstitial pulmonary disease (HP:0006530) | 1.78461424 |
| 127 | Acrocyanosis (HP:0001063) | 1.77213589 |
| 128 | Facial edema (HP:0000282) | 1.76658714 |
| 129 | Bladder diverticulum (HP:0000015) | 1.76409890 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76363660 |
| 131 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76363660 |
| 132 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76363660 |
| 133 | Epistaxis (HP:0000421) | 1.76009223 |
| 134 | Aortic dissection (HP:0002647) | 1.74750856 |
| 135 | Basal ganglia calcification (HP:0002135) | 1.74666201 |
| 136 | Periorbital edema (HP:0100539) | 1.74611340 |
| 137 | Gowers sign (HP:0003391) | 1.74156364 |
| 138 | Abnormality of iron homeostasis (HP:0011031) | 1.73837723 |
| 139 | Stridor (HP:0010307) | 1.73485868 |
| 140 | Abnormal number of erythroid precursors (HP:0012131) | 1.73462260 |
| 141 | Adducted thumb (HP:0001181) | 1.72919595 |
| 142 | Mitral regurgitation (HP:0001653) | 1.72126693 |
| 143 | Abnormality of the pericardium (HP:0001697) | 1.72068645 |
| 144 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.71800639 |
| 145 | Abnormality of the aortic arch (HP:0012303) | 1.71213313 |
| 146 | Hyperacusis (HP:0010780) | 1.70636623 |
| 147 | Ragged-red muscle fibers (HP:0003200) | 1.70506673 |
| 148 | Pulmonary infiltrates (HP:0002113) | 1.69801936 |
| 149 | Abnormality of the lumbar spine (HP:0100712) | 1.69610385 |
| 150 | Soft skin (HP:0000977) | 1.69495346 |
| 151 | Calf muscle hypertrophy (HP:0008981) | 1.69153155 |
| 152 | Long palpebral fissure (HP:0000637) | 1.69020942 |
| 153 | Shallow orbits (HP:0000586) | 1.68559218 |
| 154 | Palpebral edema (HP:0100540) | 1.67918376 |
| 155 | Abnormality of the foot musculature (HP:0001436) | 1.67826446 |
| 156 | Bicuspid aortic valve (HP:0001647) | 1.67813115 |
| 157 | Pathologic fracture (HP:0002756) | 1.67666355 |
| 158 | Xerostomia (HP:0000217) | 1.67483414 |
| 159 | Spinal canal stenosis (HP:0003416) | 1.67376032 |
| 160 | Ankle contracture (HP:0006466) | 1.66850038 |
| 161 | Hemoptysis (HP:0002105) | 1.65889806 |
| 162 | Mucopolysacchariduria (HP:0008155) | 1.65731805 |
| 163 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.65731805 |
| 164 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.65421204 |
| 165 | Spondylolisthesis (HP:0003302) | 1.64804555 |
| 166 | Thoracic kyphosis (HP:0002942) | 1.64776194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LIMK1 | 3.47636319 |
| 2 | SIK3 | 3.23053084 |
| 3 | TESK1 | 3.09776887 |
| 4 | BLK | 3.07547896 |
| 5 | PIM2 | 2.95639701 |
| 6 | ERN1 | 2.91198451 |
| 7 | TESK2 | 2.73899674 |
| 8 | NME2 | 2.65731586 |
| 9 | TRIB3 | 2.43785156 |
| 10 | SIK1 | 2.37198634 |
| 11 | TBK1 | 2.20436867 |
| 12 | PRPF4B | 2.13370212 |
| 13 | MAP3K12 | 1.99403997 |
| 14 | MAP3K10 | 1.88272496 |
| 15 | TAOK1 | 1.82211222 |
| 16 | IRAK4 | 1.81347914 |
| 17 | MAPKAPK3 | 1.80479047 |
| 18 | TNK2 | 1.78732679 |
| 19 | DYRK3 | 1.74902006 |
| 20 | DYRK2 | 1.72638319 |
| 21 | RIPK4 | 1.70188764 |
| 22 | IRAK3 | 1.69601651 |
| 23 | PRKD2 | 1.68784455 |
| 24 | MARK2 | 1.58704644 |
| 25 | EPHA3 | 1.55879388 |
| 26 | EPHB2 | 1.55622092 |
| 27 | MAP3K11 | 1.53929374 |
| 28 | MAP4K1 | 1.53440243 |
| 29 | ZAP70 | 1.51673264 |
| 30 | ICK | 1.51149364 |
| 31 | IRAK1 | 1.50954307 |
| 32 | KIT | 1.43243145 |
| 33 | DYRK1B | 1.41708884 |
| 34 | ILK | 1.37880493 |
| 35 | RPS6KA2 | 1.34310928 |
| 36 | SIK2 | 1.32251476 |
| 37 | SMG1 | 1.30690776 |
| 38 | MAP3K13 | 1.29190937 |
| 39 | RPS6KA4 | 1.27790169 |
| 40 | BTK | 1.25725577 |
| 41 | LRRK2 | 1.25407130 |
| 42 | PRKD3 | 1.23442389 |
| 43 | MAP2K3 | 1.23059612 |
| 44 | GRK6 | 1.22765780 |
| 45 | OBSCN | 1.22338128 |
| 46 | MAP3K1 | 1.22072912 |
| 47 | STK16 | 1.21611815 |
| 48 | FES | 1.20304803 |
| 49 | MAPK12 | 1.18651027 |
| 50 | KDR | 1.17892194 |
| 51 | MATK | 1.14746969 |
| 52 | PAK4 | 1.10504903 |
| 53 | ARAF | 1.10068510 |
| 54 | FGFR4 | 1.09050953 |
| 55 | CSK | 1.08260233 |
| 56 | CLK1 | 1.07971412 |
| 57 | EIF2AK1 | 1.07651700 |
| 58 | RPS6KA6 | 1.07152269 |
| 59 | RIPK1 | 1.06985874 |
| 60 | IKBKE | 1.02112187 |
| 61 | CDK19 | 1.01624861 |
| 62 | EPHB1 | 1.00092467 |
| 63 | TAOK2 | 0.99803620 |
| 64 | ERBB3 | 0.98204655 |
| 65 | IRAK2 | 0.97370797 |
| 66 | RPS6KL1 | 0.96555564 |
| 67 | RPS6KC1 | 0.96555564 |
| 68 | BUB1 | 0.95478365 |
| 69 | CAMKK1 | 0.93113144 |
| 70 | MAP2K2 | 0.92554862 |
| 71 | UHMK1 | 0.91429575 |
| 72 | TXK | 0.91268314 |
| 73 | PHKG2 | 0.90826387 |
| 74 | PHKG1 | 0.90826387 |
| 75 | MAP3K6 | 0.90226657 |
| 76 | MYLK | 0.90186437 |
| 77 | SCYL2 | 0.88290989 |
| 78 | HIPK2 | 0.88195903 |
| 79 | PDPK1 | 0.87985527 |
| 80 | MAP3K7 | 0.86740979 |
| 81 | SYK | 0.85065718 |
| 82 | INSRR | 0.82432598 |
| 83 | MAPKAPK2 | 0.82028938 |
| 84 | MAP2K4 | 0.80121986 |
| 85 | YES1 | 0.79316414 |
| 86 | STK38 | 0.77548633 |
| 87 | MAP3K14 | 0.77544182 |
| 88 | MOS | 0.77448236 |
| 89 | FGFR3 | 0.76965483 |
| 90 | CDC42BPA | 0.75466976 |
| 91 | DMPK | 0.73626462 |
| 92 | TYK2 | 0.71987827 |
| 93 | PIK3CG | 0.71835318 |
| 94 | PAK6 | 0.71120314 |
| 95 | ACVR1B | 0.70501047 |
| 96 | JAK3 | 0.69853955 |
| 97 | MARK3 | 0.68865408 |
| 98 | TYRO3 | 0.68520571 |
| 99 | TGFBR2 | 0.68471635 |
| 100 | TEC | 0.67981724 |
| 101 | MUSK | 0.67736301 |
| 102 | IKBKB | 0.66297483 |
| 103 | CSF1R | 0.65765659 |
| 104 | MINK1 | 0.65608953 |
| 105 | LYN | 0.65257400 |
| 106 | PDK1 | 0.63484504 |
| 107 | PTK6 | 0.62312532 |
| 108 | CAMKK2 | 0.61078233 |
| 109 | PAK1 | 0.59890119 |
| 110 | TTN | 0.59818113 |
| 111 | HCK | 0.59631308 |
| 112 | ITK | 0.58765225 |
| 113 | MAPK13 | 0.58458122 |
| 114 | KSR2 | 0.57420453 |
| 115 | PRKD1 | 0.57364802 |
| 116 | PKN2 | 0.57086574 |
| 117 | PTK2 | 0.56008549 |
| 118 | DAPK3 | 0.54583802 |
| 119 | ABL2 | 0.51056404 |
| 120 | BRAF | 0.50983282 |
| 121 | BCKDK | 0.50284232 |
| 122 | PIM1 | 0.50173664 |
| 123 | TRPM7 | 0.49411999 |
| 124 | MAPK4 | 0.48815897 |
| 125 | BCR | 0.48025997 |
| 126 | BMX | 0.47713457 |
| 127 | ROCK2 | 0.47605022 |
| 128 | ROCK1 | 0.47499536 |
| 129 | PRKCD | 0.47270393 |
| 130 | LCK | 0.46352759 |
| 131 | NTRK1 | 0.45660951 |
| 132 | RET | 0.44662199 |
| 133 | ADRBK2 | 0.44382737 |
| 134 | MAP3K3 | 0.44239608 |
| 135 | STK11 | 0.44172048 |
| 136 | CDK14 | 0.44055358 |
| 137 | EEF2K | 0.44035157 |
| 138 | EPHA2 | 0.44029451 |
| 139 | CHUK | 0.43255451 |
| 140 | MARK1 | 0.43113610 |
| 141 | TGFBR1 | 0.43033186 |
| 142 | FYN | 0.42858775 |
| 143 | STK10 | 0.42588684 |
| 144 | CAMK1 | 0.42020268 |
| 145 | MAP2K1 | 0.41417691 |
| 146 | NEK9 | 0.40725921 |
| 147 | RPS6KA5 | 0.39441965 |
| 148 | CDK8 | 0.38956360 |
| 149 | DDR2 | 0.38449286 |
| 150 | LMTK2 | 0.38428615 |
| 151 | CDK18 | 0.38231554 |
| 152 | AURKA | 0.37053029 |
| 153 | PRKG2 | 0.35693505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.61131319 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34130229 |
| 3 | Shigellosis_Homo sapiens_hsa05131 | 2.27813465 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.11698741 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.06352596 |
| 6 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.98492291 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 1.92074033 |
| 8 | Phagosome_Homo sapiens_hsa04145 | 1.81977783 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 1.77685834 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74897817 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.74301999 |
| 12 | Salmonella infection_Homo sapiens_hsa05132 | 1.73764917 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.70450694 |
| 14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.69972583 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.59225028 |
| 16 | Apoptosis_Homo sapiens_hsa04210 | 1.55286691 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.54829012 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.53855681 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.42523686 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.41216960 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39302436 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.38028347 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38002477 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36944521 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.36668126 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36519274 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34496749 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.33745200 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.33044215 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33019227 |
| 31 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.31262740 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28865901 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25064110 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20177112 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19823764 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.18927978 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17689534 |
| 38 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.15558804 |
| 39 | DNA replication_Homo sapiens_hsa03030 | 1.15125290 |
| 40 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.12816565 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.12630620 |
| 42 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.12092090 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11056932 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.08492086 |
| 45 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.08348311 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06841666 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.05640642 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05522537 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.05200749 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04473677 |
| 51 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.03571464 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03151248 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02822585 |
| 54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.02778513 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02473449 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01378918 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.00555486 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99191586 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.98116193 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.97630253 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95978571 |
| 62 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95862488 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94984229 |
| 64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.93686145 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.92753395 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92172852 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90892120 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.88447312 |
| 69 | Parkinsons disease_Homo sapiens_hsa05012 | 0.87899604 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86918604 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 0.86906436 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86509708 |
| 73 | Protein export_Homo sapiens_hsa03060 | 0.85920551 |
| 74 | Spliceosome_Homo sapiens_hsa03040 | 0.85533049 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85198874 |
| 76 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84334106 |
| 77 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84028513 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.83925968 |
| 79 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.83724094 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83514504 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83072930 |
| 82 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.81485001 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.79939863 |
| 84 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.79905836 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.79895298 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79278375 |
| 87 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79251595 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79227837 |
| 89 | Asthma_Homo sapiens_hsa05310 | 0.78236503 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.77339453 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76480405 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75387412 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75178615 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73412733 |
| 95 | Allograft rejection_Homo sapiens_hsa05330 | 0.72438130 |
| 96 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72239594 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70806900 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70658379 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70168529 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69704272 |
| 101 | RNA polymerase_Homo sapiens_hsa03020 | 0.69647678 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.69373931 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68587762 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68042788 |
| 105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67614374 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67203040 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67083159 |
| 108 | Cell cycle_Homo sapiens_hsa04110 | 0.66525960 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66302936 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.65864623 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65236142 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65182548 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64158589 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63625683 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63613374 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63598555 |
| 117 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63554448 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.63239809 |
| 119 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63034531 |
| 120 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61011883 |
| 121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60682768 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60569958 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59744804 |
| 124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58357763 |
| 125 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58265279 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57223281 |
| 127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57220008 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57015307 |
| 129 | Amoebiasis_Homo sapiens_hsa05146 | 0.56834539 |
| 130 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56518003 |
| 131 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.55951567 |
| 132 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55864217 |
| 133 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55236724 |
| 134 | Axon guidance_Homo sapiens_hsa04360 | 0.54540226 |
| 135 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53381965 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52944879 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.52089316 |
| 138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51471755 |
| 139 | Melanoma_Homo sapiens_hsa05218 | 0.49489113 |
| 140 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49044798 |

